Sleep apnea affects an estimated 22 million Americans, cutting off oxygen during sleep and leading to high blood pressure, ...

In the past week, Inspire Medical Systems reported operational setbacks in the launch of its Inspire V sleep apnea device, including delays in training, technology implementation, and inventory ...

CMS boosts 2026 reimbursement for Inspire Medical’s sleep apnea implant, driving shares up 28%. Read more here.

Medical device manufacturer Inspire Medical Systems, Inc. is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company ...

Nyxoah today announced a significant reimbursement win through the U.S. Centers for Medicare & Medicaid Services (CMS).

Medical device manufacturer Inspire Medical Systems, Inc. is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company ...

Investing.com -- Inspire Medical Systems (NYSE:INSP) stock soared 18% after the U.S. government released final 2026 reimbursement rules that dramatically increase payment rates for the company’s ...

Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 15.6% in the afternoon session after the ...

Barkley OKRP is debuting a new spot for Inspire Medical Systems, a tech provider of sleep apnea treatment. The agency was ...

On this ews, Inspire's stock price fell $42.04, or 32.4%, to close at $87.91 per share on August 5, 2025, thereby injuring investors. What Is The Lawsuit About?

Detailed price information for Inspire Medical Systems Inc (INSP-N) from The Globe and Mail including charting and trades.